Manfred Juraschek

Title: Manfred Juraschek: Innovator in Hematology

Introduction

Manfred Juraschek is a notable inventor based in Weimar, Germany. He has made significant contributions to the field of hematology, particularly in the development of treatments related to blood coagulation disorders. His work has been instrumental in advancing medical science and improving patient outcomes.

Latest Patents

Juraschek holds a patent for a concentrate of a factor VIII:C-containing von Willebrand factor and the process relating thereto. This invention focuses on a concentrate and a process for producing a factor VIII:C-containing von Willebrand factor through fractional precipitation from a liquid that includes both factor VIII:C and von Willebrand factor. The result is an increased content of high molecular weight multimers of von Willebrand factor, achieving a ratio of the vWF:RCoF activity to vWF:Ag of greater than 1. This innovation is crucial for enhancing the efficacy of treatments for patients with bleeding disorders.

Career Highlights

Manfred Juraschek is associated with CSL Behring GmbH, a leading global biopharmaceutical company that specializes in the development of therapies for bleeding disorders. His work at CSL Behring has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and product development.

Collaborations

Throughout his career, Juraschek has worked alongside talented colleagues, including Gerhardt Kumpe and Natascha Mayer. These collaborations have fostered an environment of innovation and have led to advancements in the understanding and treatment of blood-related conditions.

Conclusion

Manfred Juraschek's contributions to the field of hematology through his innovative patent and collaborative efforts highlight his commitment to improving medical treatments. His work continues to impact the lives of patients with bleeding disorders, showcasing the importance of innovation in healthcare.